Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Ozempic
Ozempic
Ozempic-Like Drugs May Hold Risks For Surgical Patients, Officials Say
Forbes
Fri, 01/31/25 - 10:59 am
surgery
GLP-1 agonists
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Zepbound
Mounjaro
FDA approves new indication for Ozempic to lower kidney risks in type 2 diabetes, CKD
Healio
Tue, 01/28/25 - 09:42 pm
Novo Nordisk
FDA
Ozempic
kidney disease
Large study of Novo, Lilly weight loss drugs shows decrease in risk of Alzheimer's
Fierce Pharma
Tue, 01/21/25 - 07:13 pm
Novo Nordisk
Eli Lilly
GLP-1 agonists
Wegovy
Ozempic
Zepbound
Mounjaro
Alzheimer's disease
arthritis
Ozempic tops new Medicare price negotiation list
Pharmaphorum
Fri, 01/17/25 - 11:10 am
Novo Nordisk
Ozempic
Wegovy
Rybelsus
HHS
Inflation Reduction Act
Medicare
Use of diabetes and anti-obesity drugs surges nationwide
Axios
Fri, 01/3/25 - 10:07 am
obesity
diabetes
Eli Lilly
Novo Nordisk
Ozempic
Wegovy
Mounjaro
Zepbound
GLP-1 agonist
Novo Nordisk's Ozempic reportedly linked to vision loss in new study
Yahoo Finance
Mon, 12/16/24 - 11:39 am
Novo Nordisk
Ozempic
vision loss
Biden proposes Medicare and Medicaid cover weight loss drugs
Axios
Tue, 11/26/24 - 09:51 am
Joe Biden
Medicare
Medicaid
obesity
Novo Nordisk
Eli Lilly
Zepbound
Wegovy
Ozempic
Survey Finds Most GLP-1 Users Discontinue Drug Before Reaching Goal Weight
Xtalks
Fri, 11/15/24 - 11:27 am
Omada Health
GLP-1 agonists
obesity
weight loss
Novo Nordisk
Eli Lilly
Ozempic
Zepbound
Mounjaro
Wegovy
Compounded Ozempic tied to deaths, hospitalizations: Novo Nordisk CEO
Beckers Hospital Review
Thu, 11/7/24 - 11:14 am
Novo Nordisk
Ozempic
semaglutide
compounded drugs
FDA adds aspiration warning to Ozempic, Mounjaro and other GLP-1 labels
Beckers Hospital Review
Wed, 11/6/24 - 08:01 pm
FDA
warnings
aspiration
Ozempic
Wegovy
Saxenda
Mounjaro
Novo Nordisk
Eli Lilly
Novo takes big step toward ending Ozempic, Wegovy shortages
BioPharma Dive
Wed, 10/30/24 - 08:48 pm
Novo Nordisk
drug shortages
obesity
Ozempic
Wegovy
FDA’s GLP-1 decision kicks off ‘unprecedented’ tussle over shortage
Pharma Voice
Mon, 10/21/24 - 09:37 am
FDA
GLP-1 agonists
Ozempic
Wegovy
Novo Nordisk
drug shortages
Eli Lilly
Zepbound
Chinese insulin maker says its GLP-1 beat Ozempic at lowering blood sugar, body weight in phase 2
Fierce Biotech
Wed, 10/16/24 - 12:17 pm
Gan & Lee
GLP-1
Novo Nordisk
Ozempic
type 2 diabetes
Amid GLP-1 craze, Novo and Mylan ink patent settlement in Ozempic case
Fierce Pharma
Mon, 10/7/24 - 09:56 pm
Mylan Labs
Natco
Novo Nordisk
Ozempic
generics
patents
legal
Novo Nordisk has mitigation plans to minimize disruption from port strikes
Reuters
Thu, 10/3/24 - 11:47 am
Novo Nordisk
logistics
labor strike
Wegovy
Ozempic
Weight Loss From GLP-1 Drugs Not As Robust In Real-World Settings
Forbes
Wed, 10/2/24 - 11:20 am
weight loss
obesity
GLP-1 agonist
Ozempic
Wegovy
Novo Nordisk
Zepbound
Mounjaro
Eli Lilly
Patients sue over alleged stomach paralysis linked to Ozempic, Mounjaro
Beckers Hospital Review
Tue, 10/1/24 - 10:45 am
legal
Novo Nordisk
Eli Lilly
Ozempic
Mounjaro
gastroparesis
Ozempic linked to lower opioid overdose rate in those with diabetes, study shows
Stat
Wed, 09/25/24 - 12:04 pm
Novo Nordisk
Ozempic
opioid addiction
Rybelsus
type 2 diabetes
Inside the GLP-1 'price war'
Beckers Hospital Review
Tue, 09/24/24 - 11:52 am
GLP-1 agonists
obesity
weight loss
Eli Lilly
Novo Nordisk
Ozempic
Wegovy
Zepbound
Mounjaro
drug pricing
U.S. Senator Sanders says pharmacy middlemen commit to expanding weight-loss drug coverage if prices cut
Reuters
Tue, 09/24/24 - 11:40 am
Bernie Sanders
PBMs
Novo Nordisk
Ozempic
Wegovy
drug pricing
Pages
1
2
3
4
5
6
7
8
9
next ›
last »